|
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 37510234 | The <i>APOBEC3B</i> c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. | Genes (Basel) | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37292833 | Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry. | medRxiv | 2023 |
| 37025481 | Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variants. | BJUI Compass | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37312208 | Genetic testing for hereditary breast cancer in Poland: 1998-2022. | Hered Cancer Clin Pract | 2023 |
| 37311464 | Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. | Am J Hum Genet | 2023 |
| 37108398 | Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. | Int J Mol Sci | 2023 |
| 36977412 | Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank. | Am J Hum Genet | 2023 |
| 37299574 | Serum Essential Elements and Survival after Cancer Diagnosis. | Nutrients | 2023 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35442721 | Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2. | JCO Precis Oncol | 2022 |
| 35382848 | Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland. | Hered Cancer Clin Pract | 2022 |
| 35732815 | An appraisal of genetic testing for prostate cancer susceptibility. | NPJ Precis Oncol | 2022 |
| 35712517 | High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival. | Front Oncol | 2022 |
| 36551774 | Serum Iron Level and 10-Year Survival after Melanoma. | Biomedicines | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 35313928 | Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor. | Hered Cancer Clin Pract | 2022 |
| 35152271 | Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. | Prostate Cancer Prostatic Dis | 2022 |
| 34906988 | Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools. | Cancer Prev Res (Phila) | 2022 |
| 35205705 | Risk of Second Primary Thyroid Cancer in Women with Breast Cancer. | Cancers (Basel) | 2022 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |
| 33623038 | Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. | Nat Commun | 2021 |
| 33670479 | Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer. | Cancers (Basel) | 2021 |
| 33809461 | Serum Selenium Level Predicts 10-Year Survival after Breast Cancer. | Nutrients | 2021 |
| 34440195 | Serum Selenium Level and 10-Year Survival after Melanoma. | Biomedicines | 2021 |
| 34439826 | Influence of the Levels of Arsenic, Cadmium, Mercury and Lead on Overall Survival in Lung Cancer. | Biomolecules | 2021 |
| 34499690 | Survival of bladder or renal cancer in patients with CHEK2 mutations. | PLoS One | 2021 |
| 34461861 | Genetic predisposition to male breast cancer in Poland. | BMC Cancer | 2021 |
| 34572288 | Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women. | Biomedicines | 2021 |
| 34771627 | Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer? | Cancers (Basel) | 2021 |
| 34829856 | Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland. | Biomedicines | 2021 |
| 34283078 | Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> Carriers. | Cancers (Basel) | 2021 |
| 33249371 | Blood cadmium levels as a marker for early lung cancer detection. | J Trace Elem Med Biol | 2021 |
| 33398198 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33420416 | Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. | Prostate Cancer Prostatic Dis | 2021 |
| 33473200 | Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33419454 | Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population. | Hered Cancer Clin Pract | 2021 |
| 33478551 | BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update. | Hered Cancer Clin Pract | 2021 |
| 32888145 | Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population. | Breast Cancer | 2021 |
| 32648197 | Lung Cancer Occurrence-Correlation with Serum Chromium Levels and Genotypes. | Biol Trace Elem Res | 2021 |
| 31348523 | Blood arsenic levels and the risk of familial breast cancer in Poland. | Int J Cancer | 2020 |
| 33158149 | The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. | Cancers (Basel) | 2020 |
| 33322519 | CA125 and Ovarian Cancer: A Comprehensive Review. | Cancers (Basel) | 2020 |
| 32976206 | Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population. | Eur J Cancer Prev | 2020 |
| 32824581 | Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland. | Cancers (Basel) | 2020 |
| 32765800 | Polymorphisms in <i>MMP-1</i>, <i>MMP-2</i>, <i>MMP-7, MMP-13</i> and <i>MT2A</i> do not contribute to breast, lung and colon cancer risk in polish population. | Hered Cancer Clin Pract | 2020 |
| 32875559 | Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. | Int J Cancer | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |